Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Affymax rises after analyst sets 'Outperform' rating, ahead of FDA ruling on anemia drug
Affymax rises after analyst sets 'Outperform' rating, ahead of FDA ruling on anemia drug
Affymax rises after analyst sets 'Outperform' rating, ahead of FDA ruling on anemia drug
Submitted by
admin
on March 24, 2012 - 11:31am
Source:
Yahoo/AP
News Tags:
peginesatide
anemia
Affymax
Headline:
Affymax rises after analyst sets 'Outperform' rating, ahead of FDA ruling on anemia drug
Do Not Allow Advertisers to Use My Personal information
